New diabetes clinical trial: A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Published on: November 27, 2025 at 11:00PM
Conditions: Overweight; Obesity
Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Placebo cagrilintide; Drug: Placebo semaglutide
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/EZ8JfeD

Comments